Evidence map›Paper›PMID 42724454›Full record

ArticleRSC advances2026

Controlled aqueous nanoassembly-driven fully automated Fmoc solid-phase peptide synthesis (SPPS) with in-water coupling.

Keiko Hojo, Mutsumi Kishimoto, Ayana Nagai, Cédric Rentier, Amit Mehrotra, Kazuhito Hioki, Munetaka Kunishima

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Keiko HojoFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan hojo@pharm.kobegakuin.ac.jp kunisima@pharm.kobegakuin.ac.jp.ORCID https://orcid.org/0000-0002-1692-3948
Mutsumi KishimotoFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan hojo@pharm.kobegakuin.ac.jp kunisima@pharm.kobegakuin.ac.jp.
Ayana NagaiFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan hojo@pharm.kobegakuin.ac.jp kunisima@pharm.kobegakuin.ac.jp.
Cédric RentierBiotage Japan Ltd Tokyo 136-0071 Japan.
Amit MehrotraBiotage Sweden AB Uppsala 753-18 Sweden.ORCID https://orcid.org/0009-0008-6758-3294
Kazuhito HiokiFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan hojo@pharm.kobegakuin.ac.jp kunisima@pharm.kobegakuin.ac.jp.
Munetaka KunishimaFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan hojo@pharm.kobegakuin.ac.jp kunisima@pharm.kobegakuin.ac.jp.ORCID https://orcid.org/0000-0002-3296-490X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fmoc-based solid-phase peptide synthesis (SPPS) is a cornerstone of modern peptide manufacturing; however, its reliance on dimethylformamide (DMF)-a toxic and environmentally regulated solvent-poses significant sustainability challenges. Herein, we report a controlled aqueous nanoassembly-based strategy that enables fully automated Fmoc-SPPS under water-based coupling conditions. Aqueous nanoassemblies of Fmoc-protected amino acids, generated through a simple two-step preparation protocol, provide a stable and reactive coupling environment compatible with automated synthesis. The methodology was implemented on a commercially available peptide synthesizer and applied to peptides of varying lengths and sequence complexities, affording products of acceptable purity. Importantly, the platform was applied to the automated synthesis of long-chain peptides exceeding 30 residues, including GLP-1 (1-37), demonstrating its applicability to challenging sequences. At the time of writing, this represents, to the best of our knowledge, one of the earliest fully automated Fmoc-SPPS platforms employing water-based coupling cycles without the use of DMF. By eliminating DMF and employing environmentally benign solvents such as water and ethyl acetate, the present methodology provides a practical and sustainable alternative to conventional SPPS, advancing green practices in automated peptide synthesis.

Identifiers

PMID42724454
PMCPMC13559539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.